Z-VAD-FMK 

To Order Contact us: stephen@expresspharmapulse.com

Z-VAD-FMK
A1902-25 25 mg
EUR 514
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK
A1902-5 5 mg
EUR 224
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK
A1902-5.1 10 mM (in 1mL DMSO)
EUR 224
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK
1140-1
EUR 294

Z-VAD-FMK
1140-5
EUR 805

Z-VAD(OMe)-FMK
HY-16658 10mg
EUR 394

Z-VAD-FMK, cell permeable
GL1523-1MG 1 mg
EUR 275

Z-VAD-FMK, cell permeable
GL1523-5MG 5 mg
EUR 792

Caspase-Family Inhibitor Z-VAD-FMK
1010-100
EUR 196

Caspase-Family Inhibitor Z-VAD-FMK
1010-20C
EUR 196

SRB-VAD-FMK [Sulforhodamine B-VAD-FMK]
13472 25 Tests
EUR 132

Z-VAD-FMK (Pan-specific caspase inhibitor)
SIH-557-1MG 1 mg
EUR 193
Description: The substance Z-VAD-FMK is a pan-specific caspase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is lyophilized solid or wax which is May be dissolved in DMSO (10 mg/ml).

TF4-VAD-FMK
13471 25 Tests
EUR 132

Biotin-VAD-FMK
HY-100894 1mg
EUR 1014

FITC-VAD-FMK
9497-100
EUR 359

Biotin-VAD-FMK
1123-20C
EUR 327

mFluor™ 450-VAD-FMK
13475 25 Tests
EUR 132

mFluor™ 510-VAD-FMK
13476 25 Tests
EUR 132

Z-DEVD-FMK
HY-12466 10mg
EUR 393

Z-IETD-FMK
HY-101297 5mg
EUR 463

Z-VRPR-FMK
GL3755-1MG 1 mg
EUR 585

Z-VRPR-FMK
GL3755-500UG 500 ug
EUR 355

Z-IETD-FMK
B3232-1 1 mg
EUR 328
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-IETD-FMK
B3232-5 5 mg
EUR 456
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-IETD-FMK
B3232-5.1 10 mM (in 1mL DMSO)
EUR 1001
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-LEHD-FMK
B3233-1 1 mg
EUR 350
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Z-LEHD-FMK
B3233-5 5 mg
EUR 879
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Z-FA-FMK
A8170-1 1 mg
EUR 119
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK
A8170-10 10 mg
EUR 467
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK
A8170-25 25 mg
EUR 514
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK
A8170-5 5 mg
EUR 282
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK
A8170-5.1 10 mM (in 1mL DMSO)
EUR 340
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK
A8170-S Evaluation Sample
EUR 81
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-DEVD-FMK
A1920-1 1 mg
EUR 113
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-10 10 mg
EUR 340
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-25 25 mg
EUR 514
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-5 5 mg
EUR 224
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-5.1 10 mM (in 1mL DMSO)
EUR 293
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-S Evaluation Sample
EUR 81
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DQMD-FMK
A1921-1 1 mg
EUR 113
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK
A1921-10 10 mg
EUR 340
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK
A1921-25 25 mg
EUR 514
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK
A1921-5 5 mg
EUR 224
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK
A1921-5.1 10 mM (in 1mL DMSO)
EUR 432
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK
A1921-S Evaluation Sample
EUR 81
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-VDVAD-FMK
A1922-1 1 mg
EUR 177
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK
A1922-10 10 mg
EUR 630
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK
A1922-25 25 mg
EUR 978
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK
A1922-5 5 mg
EUR 398
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK
A1922-S Evaluation Sample
EUR 81
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VEID-FMK
A1923-1 1 mg
EUR 177
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK
A1923-10 10 mg
EUR 630
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK
A1923-25 25 mg
EUR 978
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK
A1923-5 5 mg
EUR 398
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK
A1923-S Evaluation Sample
EUR 81
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-WEHD-FMK
A1924-1 1 mg
EUR 113
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK
A1924-10 10 mg
EUR 340
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK
A1924-25 25 mg
EUR 514
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK
A1924-5 5 mg
EUR 224
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-YVAD-FMK
A8955-1 1 mg
EUR 235
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-YVAD-FMK
A8955-5 5 mg
EUR 514
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-YVAD-FMK
A8955-5.1 10 mM (in 1mL DMSO)
EUR 1105
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-AEVD-FMK
B1162-1
EUR 338

Z-AEVD-FMK
B1162-5
EUR 914

Z-VRPR-FMK
B1238-1000
EUR 914

Z-VRPR-FMK
B1238-250
EUR 338

Z-YVAD-FMK
1141-1
EUR 338

Z-YVAD-FMK
1141-5
EUR 805

Z-VDVAD-FMK
1142-1
EUR 305

Z-VDVAD-FMK
1142-5
EUR 805

Z-DEVD-FMK
1143-1
EUR 316

Z-DEVD-FMK
1143-5
EUR 805

Z-LEVD-FMK
1144-1
EUR 316

Z-LEVD-FMK
1144-5
EUR 805

Z-VEID-FMK
1146-1
EUR 305

Z-VEID-FMK
1146-5
EUR 805

Z-IETD-FMK
1148-1
EUR 327

Z-IETD-FMK
1148-5
EUR 784

Z-LEHD-FMK
1149-1
EUR 316

Z-LEHD-FMK
1149-5
EUR 767

Z-ATAD-FMK
1152-1
EUR 349

Z-ATAD-FMK
1152-5
EUR 914

Z-FA-FMK
1986-1
EUR 147

Z-FA-FMK
1986-5
EUR 370

Calpain Inhibitor, Z-LLY-FMK
B1506-1000
EUR 338

Calpain Inhibitor, Z-LLY-FMK
B1506-250
EUR 218

Caspase-8 Inhibitor Z-IETD-FMK
B4096-.02 20 µl (10 mM)
EUR 195
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Caspase-8 Inhibitor Z-IETD-FMK
B4096-.1 100 µl (2 mM)
EUR 195
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Caspase-9 Inhibitor Z-LEHD-FMK
B4573-.02 20 µl (10 mM)
EUR 195
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Caspase-9 Inhibitor Z-LEHD-FMK
B4573-.1 100 µl (2 mM)
EUR 195
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Caspase-3 Inhibitor Z-DEVD-FMK
1009-100
EUR 207

Caspase-3 Inhibitor Z-DEVD-FMK
1009-20C
EUR 207

Caspase-6 Inhibitor Z-VEID-FMK
1011-100
EUR 185

Caspase-6 Inhibitor Z-VEID-FMK
1011-20C
EUR 185

Caspase-1 Inhibitor Z-YVAD-FMK
1012-100
EUR 196

Caspase-1 Inhibitor Z-YVAD-FMK
1012-20C
EUR 196

Caspase-8 Inhibitor Z-IETD-FMK
1064-100
EUR 196

Caspase-8 Inhibitor Z-IETD-FMK
1064-20C
EUR 196

Caspase-2 Inhibitor Z-VDVAD-FMK
1073-100
EUR 185

Caspase-2 Inhibitor Z-VDVAD-FMK
1073-20C
EUR 185

Caspase-9 Inhibitor Z-LEHD-FMK
1074-100
EUR 207

Caspase-9 Inhibitor Z-LEHD-FMK
1074-20C
EUR 207

Caspase-12 Inhibitor Z-ATAD-FMK
1079-100
EUR 218

Caspase-12 Inhibitor Z-ATAD-FMK
1079-20C
EUR 218

Caspase-5 Inhibitor Z-WEHD-FMK
1100-100
EUR 196

Caspase-5 Inhibitor Z-WEHD-FMK
1100-20C
EUR 196

Caspase-4 Inhibitor Z-LEVD-FMK
1108-100
EUR 185

Caspase-4 Inhibitor Z-LEVD-FMK
1108-20C
EUR 185

EZSolution? Calpain Inhibitor, Z-LLY-FMK
1125-20C
EUR 185

EMAP-II Inhibitor Z-ASTD-FMK
1127-20C
EUR 262

Caspase-3 inhibitor, Z-DQMD-FMK
2782-1
EUR 142

Caspase-3 inhibitor, Z-DQMD-FMK
2782-5
EUR 414

Cathepsin B&L Inhibitor Z-Phe-Phe-FMK
1126-20C
EUR 229

FMK
HY-52101A 10mM/1mL
EUR 336

FMK
A3420-10 10 mg
EUR 373
Description: FMK is a potent, highly specific and irreversible ribosomal s6 kinase (RSK) inhibitor with IC50 value of 15 nM.[1]RSK is named for ribosomal protein s6, part of the translational machinery which are serine/threonine kinases and are activated by the MAPK/ERK pathway.

FMK-MEA
HY-52101C 5mg
EUR 681

FMK 9a
HY-100522 10mM/1mL
EUR 467

BOC-Asp(OMe)-FMK [Boc-D(OMe)-FMK]
5311 10 mg
EUR 480

FAM-LETD-FMK
13416 100 ug
EUR 263

BOC-D-FMK
HY-13229 1mg
EUR 119

Boc-D-FMK
A1904-1 1 mg
EUR 108
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK
A1904-10 10 mg
EUR 311
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK
A1904-25 25 mg
EUR 630
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK
A1904-5 5 mg
EUR 224
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK
A1904-5.1 10 mM (in 1mL DMSO)
EUR 218
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

FITC-VDVAD-FMK
9498-100
EUR 359

Z-VAD-FMK